North Chicago Business
-
Abbott claims J&J's psoriasis drug infringes patentsAug 10, 2009 11:00 pm - Abbott Laboratories, which is fighting to void a $1.67 billion patent-infringement verdict won by Johnson & Johnson's Centocor unit, filed a lawsuit claiming a J&J drug ...
-
J&J: Abbott owes $2.1 billion in Humira royaltiesJun 22, 2009 11:00 pm - Johnson & Johnson's Centocor told a U.S. jury today it was entitled to a $2.1 billion slice of the revenue Abbott Laboratories gets from selling the arthritis drug Humir...
-
Abbott submits application for cholesterol drugJun 03, 2009 11:00 pm - Abbott and AstraZeneca announced that they have submitted a new drug application to the U.S. Food and Drug Administration for the treatment of dyslipidemia. The investig...
-
Abbott sues Johnson & Johnson to block arthritis drug SimponiMay 03, 2009 11:00 pm - Abbott Laboratories, maker of the rheumatoid arthritis drug Humira, sued Johnson & Johnson's Centocor unit to prevent it from introducing a competing medicine for the cr...
-
Abbott accused of misleading workers who joined HospiraApr 22, 2009 11:00 pm - Abbott Laboratories was accused at the start of a federal trial of misleading former employees about their retirement benefits to induce them to join a spinoff business....
-
Abbott 1Q profit rises on one-time itemsApr 14, 2009 11:00 pm - WASHINGTON -- Abbott Laboratories reported a first-quarter profit that edged past Wall Street expectations, though analysts focused on weaker sales growth for its blockb...
-
Abbott Labs sues Sandoz over kidney drugMar 31, 2009 11:00 pm - Abbott Laboratories, the maker of blood-sugar monitors and heart stents, sued generic drugmaker Sandoz AG, which plans to produce and market a version of the Zemplar dru...
-
Abbott, Northrup, Verizon to raise dividendsMar 08, 2009 11:00 pm - Altria Group Inc., AT&T Inc. and Procter & Gamble Co. are among 34 large U.S. companies that are likely to boost dividends, and investors should buy their stocks as the ...
-
Humira sales lift Abbott 4Q profit 28 percentJan 20, 2009 10:00 pm - Sales of Abbott Laboratories' blockbuster drug Humira combined with double-digit growth of medical devices and nutritionals to push profit up 28 percent in the fourth qu...
-
Abbott's White: It's a 'good time' to buy health care companiesJan 20, 2009 10:00 pm - Abbott Laboratories, with $3.77 billion in cash, is looking to buy non-pharmaceutical companies beaten down by the recession, joining other big drugmakers shopping for b...